Bulk Manufacturer of Controlled Substances Application: Specgx, LLC, 51983-51984 [2018-22415]
Download as PDF
<![CDATA[
51983
Federal Register / Vol. 83, No. 199 / Monday, October 15, 2018 / Notices
42696, 42697 (2018). ‘‘Moreover, in the
absence of an application (whether
timely filed or not), there is nothing to
act upon.’’ Reece, 77 FR at 35055,
Rampey, 83 FR at 42697. Accordingly,
because Registrant has allowed his
registration to expire and has not filed
an application to renew his registration
or for any other registration in Alabama,
this case is now moot and will be
dismissed.
Order
Pursuant to 28 CFR 0.100(b) and the
authority thus vested in me by 21 U.S.C.
824(a), I order that the Order to Show
Cause issued to Phillip O. Rawlings, Jr.,
M.D., be, and it hereby is, dismissed.
This Order is effective immediately.
[FR Doc. 2018–22421 Filed 10–12–18; 8:45 am]
BILLING CODE 4410–09–P
The
company listed below applied to be
registered as an importer of various
basic classes of controlled substances.
Information on previously published
notices is listed in the table below. No
comments or objections were submitted
and no requests for hearing were
submitted for these notices.
SUPPLEMENTARY INFORMATION:
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Registration
ACTION:
registration by the Drug Enforcement
Administration (DEA) as importers of
various classes of schedule I or II
controlled substances.
Notice of registration.
Registrant listed below have
applied for and been granted
SUMMARY:
Company
FR Docket
Galephar Pharmaceutical Research Inc .................................
83 FR 37525 ..........................................................................
The Drug Enforcement
Administration (DEA) has considered
the factors in 21 U.S.C. 823, 952(a) and
958(a) and determined that the
registration of the listed registrant to
import the applicable basic classes of
schedule I or II controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. The
DEA investigated the company’s
maintenance of effective controls
against diversion by inspecting and
testing each company’s physical
security systems, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the DEA has
granted a registration as an importer for
schedule I or II controlled substance to
the above listed company.
Dated: September 24, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018–22420 Filed 10–12–18; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
khammond on DSK30JT082PROD with NOTICES
Dated: September 26, 2018.
Uttam Dhillon,
Acting Administrator.
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Cambrex High Point, Inc.
ACTION:
Notice of application.
VerDate Sep<11>2014
21:34 Oct 12, 2018
Jkt 247001
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before November 14, 2018. Such
persons may also file a written request
for a hearing on the application on or
before November 14, 2018.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
DATES:
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
Published
August 1, 2018.
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on July 16,
2018, Cambrex High Point Inc., 4180
Mendenhall Oaks Parkway, High Point,
North Carolina 27265–8017 applied to
be registered as an importer of the
following basic classes of controlled
substances:
Controlled
substance
Drug
code
Schedule
Amphetamine ...................
Codeine ............................
Oxymorphone ...................
Noroxymorphone ..............
1100
9050
9652
9668
II
II
II
II
The company plans to manufacture
the above listed controlled substances in
bulk for distribution to its customers.
Dated: October 1, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018–22416 Filed 10–12–18; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Specgx, LLC
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
DATES:
E:\FR\FM\15OCN1.SGM
15OCN1
51984
Federal Register / Vol. 83, No. 199 / Monday, October 15, 2018 / Notices
comments on or objections to the
issuance of the proposed registration on
or before December 14, 2018.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on July 26,
2018, Specgx, LLC, 3600 North Second
Street, Saint Louis, Missouri 63147–
3457 applied to be registered as a bulk
manufacturer of the following basic
class of controlled substance:
Drug
code
Controlled substance
Fentanyl-related substances, their isomers, esters, ethers, salts and salts of isomers, esters, and ethers .................
The company plans to manufacture
the above-listed controlled substance in
gram quantities for sale as analytical
research standards.
Dated: September 24, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018–22415 Filed 10–12–18; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF LABOR
Agency Information Collection
Activities; Submission for OMB
Review; Comment Request; America’s
Promise Job-Driven Grant Program
Evaluation; Office of the Secretary
Notice of availability; request
for comments.
ACTION:
khammond on DSK30JT082PROD with NOTICES
FOR FURTHER INFORMATION CONTACT:
The Department of Labor
(DOL) is submitting the information
collection request (ICR) proposal titled,
‘‘E America’s Promise Job-Driven Grant
Program Evaluation,’’ to the Office of
Management and Budget (OMB) for
review and approval for use in
accordance with the Paperwork
Reduction Act (PRA) of 1995. Public
comments on the ICR are invited.
DATES: The OMB will consider all
written comments that agency receives
on or before November 14, 2018.
ADDRESSES: A copy of this ICR with
applicable supporting documentation;
including a description of the likely
respondents, proposed frequency of
response, and estimated total burden
may be obtained free of charge from the
RegInfo.gov website at https://
www.reginfo.gov/public/do/
PRAViewICR?ref_nbr=201801-1290-001
(this link will only become active on the
day following publication of this notice)
or by contacting Michel Smyth by
telephone at 202–693–4129 (this is not
SUMMARY:
VerDate Sep<11>2014
21:34 Oct 12, 2018
Jkt 247001
a toll-free number) or by email at DOL_
PRA_PUBLIC@dol.gov.
Submit comments about this request
by mail to the Office of Information and
Regulatory Affairs, Attn: OMB Desk
Officer for DOL–OASP, Office of
Management and Budget, Room 10235,
725 17th Street NW, Washington, DC
20503; by Fax: 202–395–5806 (this is
not a toll-free number); or by email:
OIRA_submission@omb.eop.gov.
Commenters are encouraged, but not
required, to send a courtesy copy of any
comments by mail or courier to the U.S.
Department of Labor-OASAM, Office of
the Chief Information Officer, Attn:
Departmental Information Compliance
Management Program, Room N1301,
200 Constitution Avenue NW,
Washington, DC 20210; or by email:
DOL_PRA_PUBLIC@dol.gov.
Michel Smyth by telephone at 202–693–
4129 (this is not a toll-free number) or
by email at DOL_PRA_PUBLIC@dol.gov.
This ICR
seeks PRA authority for the America’s
Promise Job-Driven Grant Program
Evaluation information collection to
support an implementation and impact
evaluation. The America’s Promise
program aims to create or expand
regional partnerships that will identify
the needs of specific industry sectors
relying on the H–1B visa program to
hire skilled foreign workers and prepare
the domestic workforce for middle- and
high-skilled, high-growth jobs in those
sectors. This evaluation offers a unique
opportunity to build knowledge about
the implementation and effectiveness of
these regional partnerships. The
information collections consist of a
grantee survey and a partner network
survey. American Competitiveness and
Workforce Improvement Act section 169
authorizes this information collection.
See 29 U.S.C. 3224(a).
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
Schedule
9850
I
This proposed information collection
is subject to the PRA. A Federal agency
generally cannot conduct or sponsor a
collection of information, and the public
is generally not required to respond to
an information collection, unless it is
approved by the OMB under the PRA
and displays a currently valid OMB
Control Number. In addition,
notwithstanding any other provisions of
law, no person shall generally be subject
to penalty for failing to comply with a
collection of information if the
collection of information does not
display a valid Control Number. See 5
CFR 1320.5(a) and 1320.6. For
additional information, see the related
notice published in the Federal Register
on July 12, 2017 (82 FR 32204).
Interested parties are encouraged to
send comments to the OMB, Office of
Information and Regulatory Affairs at
the address shown in the ADDRESSES
section within thirty (30) days of
publication of this notice in the Federal
Register. In order to help ensure
appropriate consideration, comments
should mention OMB ICR Reference
Number 201801–1290–001. The OMB is
particularly interested in comments
that:
• Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
• Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
• Enhance the quality, utility, and
clarity of the information to be
collected; and
• Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
E:\FR\FM\15OCN1.SGM
15OCN1
]]>Agencies
[Federal Register Volume 83, Number 199 (Monday, October 15, 2018)]
[Notices]
[Pages 51983-51984]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-22415]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Specgx,
LLC
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written
[[Page 51984]]
comments on or objections to the issuance of the proposed registration
on or before December 14, 2018.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on July
26, 2018, Specgx, LLC, 3600 North Second Street, Saint Louis, Missouri
63147-3457 applied to be registered as a bulk manufacturer of the
following basic class of controlled substance:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Fentanyl-related substances, their 9850 I
isomers, esters, ethers, salts and salts
of isomers, esters, and ethers.
------------------------------------------------------------------------
The company plans to manufacture the above-listed controlled
substance in gram quantities for sale as analytical research standards.
Dated: September 24, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-22415 Filed 10-12-18; 8:45 am]
BILLING CODE 4410-09-P
